AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Inspire Medical Systems, Inc.
XNYS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00209SZK5
71.11▼ 1.55 (-2.13%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
72.66
Day's Range
68.44 – 72.75
52-Week Range
38.91 – 147.03
Volume
557.0K
Avg Volume
845.5K
Share Statistics
Shares Outstanding
Employees
1,333
Exchange
XNYS
Listed
2018-05-03
Share count as of July 30, 2026

Inspire Medical Systems, Inc. (INSP) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Inspire Medical Systems, Inc. (INSP)
What is Inspire Medical Systems, Inc.'s Market Cap?
Inspire Medical Systems, Inc.'s Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Inspire Medical Systems, Inc.'s Trailing P/E?
Inspire Medical Systems, Inc.'s Trailing P/E is 15.2×, based on as-reported figures from SEC (XBRL) filings.
What is Inspire Medical Systems, Inc.'s Price / Sales?
Inspire Medical Systems, Inc.'s Price / Sales is 2.3×, based on as-reported figures from SEC (XBRL) filings.
What is Inspire Medical Systems, Inc.'s Revenue (TTM)?
Inspire Medical Systems, Inc.'s Revenue (TTM) is $898.7M, based on as-reported figures from SEC (XBRL) filings.
What is Inspire Medical Systems, Inc.'s Net Income (TTM)?
Inspire Medical Systems, Inc.'s Net Income (TTM) is $135.0M, based on as-reported figures from SEC (XBRL) filings.
What is Inspire Medical Systems, Inc.'s EBITDA?
Inspire Medical Systems, Inc.'s EBITDA is $71.3M, based on as-reported figures from SEC (XBRL) filings.
What is Inspire Medical Systems, Inc.'s Diluted EPS (TTM)?
Inspire Medical Systems, Inc.'s Diluted EPS (TTM) is 4.67, based on as-reported figures from SEC (XBRL) filings.
What is Inspire Medical Systems, Inc.'s EBITDA Margin?
Inspire Medical Systems, Inc.'s EBITDA Margin is 7.9%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · INSPAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-7.6%+1.6%+12.2%+10.5%
Cost of goods sold
Gross profit
% of revenue85.5%86.5%86.6%85.8%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
Operating income (loss)
% of revenue-0.3%-0.5%17.1%4.3%
Interest and dividend (income), net
Other expense, net
Earnings (loss) before income taxes
Income tax expense
Net earnings (loss)
% of revenue0.2%-5.5%50.6%4.4%
Basic earnings (loss) per share (in dollars per share)
Diluted earnings (loss) per share (in dollars per share)